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Glycine is the smallest and simplest possible amino acid (Fig. 1a, centre), one of the 9 
building blocks of proteins. It is synthesised and degraded in our body as part of the 10 
ubiquitous serine cycle. Since its discovery in 1820 by Henri Braconnot, it took more 11 
than a century to understand its prominent roles in the central nervous system.  12 
We now know that glycine is an important inhibitory neurotransmitter, particularly in 13 
the retina, the brainstem, and the spinal cord. It acts by activating the ionotropic 14 
glycine receptor, prompting chloride entry which hyperpolarises the neuronal 15 
membrane (Fig. 1a, left). Glycine is also a co-agonist of ionotropic NMDA receptors 16 
(NMDARs), which are activated by the common excitatory neurotransmitter 17 
glutamate (Fig. 1a, right). Because NMDAR activation requires coincidence of 18 
presynaptic glutamate release and postsynaptic cell depolarisation (which relieves 19 
their Mg2+ block), they are considered essential to the synaptic mechanism of 20 
Hebbian plasticity underpinning memory formation in the brain 1. For these receptors 21 
to function, either of the two endogenous co-agonists, glycine or D-serine, is 22 
required. Thus, the extracellular concentration of glycine (as well as D-serine) could 23 
critically control NMDAR availability hence the efficacy of plasticity induction in 24 
neural circuits 2, 3. The extracellular dynamics of glycine should therefore provide 25 
important clues about the ability of local excitatory connections to undergo memory-26 
forming changes.  27 
The core design of biosensors for glycine and other neurotransmitters has long 28 
involved micro-electrodes employing electrochemical properties of selected 29 
materials4. However, electrode-based methods can only provide macroscopic 30 
readout from one or a few sites in the tissue while being prone to signal 31 
contamination from local cell damage. The ongoing revolution in molecular optical 32 
imaging is paving the way to non-invasive, high-resolution dynamic mapping of 33 
signalling molecules in the brain 5, 6. Taking advantage of this trend, the authors in 34 
this issue 7 set out to develop an optical sensor for glycine using a computer-35 
assisted molecular design combined with targeted protein mutations. They elected to 36 
use the ratiometric FRET signal as readout because it is insensitive to fluctuations in 37 
the sensor concentration, excitation power or photobleaching. Thus, the strategy was 38 
to obtain a protein molecule which has a specific affinity to glycine and to interlink it 39 
with a FRET pair, so that the glycine-induced conformational change alters the FRET 40 
signal.  41 
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To achieve this, the authors started with the bacterial protein Atu2422 (from 42 
Agrobacterium tumefaciens), which is known to change its conformation upon the 43 
binding of glycine, L-serine, or GABA (Fig. 1b, i). The task was to redesign its 44 
binding site to suppress the affinity to L-serine and GABA. Based on the computer 45 
analyses of 3D molecular structure, the authors first produced a Phe77Ala/Ala100Tyr 46 
(AY) mutant showing no detectable GABA binding (Fig. 1b, ii), and then a 47 
Phe77Ala/Leu202Trp (AW) mutant showing neither GABA nor L-serine binding (Fig. 48 
1b, iii). However, the latter mutant turned out to display significant affinity to 49 
glutamate, prompting the authors to restore the Ala100Tyr mutation (Fig. 1b, iv). 50 
Thus, by consistently referring their mutation strategy to a computer-assisted 51 
molecular design the authors obtained the protein (AYW) showing specific glycine 52 
binding.  53 
Next, the AYW protein was cloned between the well-established FRET pair, ECFP 54 
and Venus, using flexible amino-acid-chain linkers (Fig. 1c, left). This design was 55 
further adjusted, by truncating and modifying the linkers, to maximise the FRET 56 
response to glycine binding. The resulting glycine FRET sensor termed GlyFS has 57 
reached a ~25% fluorescence dynamic range (Fig. 1c, right).  58 
To deliver the GlyFS sensor to the brain extracellular space, the authors micro-59 
injected a GlyFS-streptavidin mixture into the surface-biotinylated tissue of acute 60 
hippocampal slices. At this stage, they were using two-photon excitation microscopy 61 
combined with patch-clamp electrophysiology to map, with sub-micron resolution, 62 
GlyFS signal near visualised dendrites of principal neurons (dialysed with a 63 
chromatically distinct morphological tracer). In these settings, two physiologically 64 
significant observations have been made. Firstly, glycine tends to accumulate near 65 
dendritic shafts rather than the spines hosting excitatory synapses enriched in 66 
NMDARs (Fig. 1d, left). This observation lends further support to the hypothesis that 67 
glycine, rather than D-serine, is the main co-agonist of extrasynaptic NMDARs 3. 68 
Secondly, the authors have found that excitatory neuronal activity, either high- or 69 
low- frequency, boosts extracellular glycine levels (Fig. 1d, right).  70 
Such observations open a new horizon in our ability to monitor glycine dynamics in 71 
the nervous tissue while prompting multiple questions about its physiological 72 
implications and the underlying cellular mechanisms. In addition to mapping out and 73 
exploring inhibitory activity in the spinal cord and brainstem, some important and 74 
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intriguing quests here concern the contributing roles of neurons and astrocytes in 75 
regulating extracellular glycine and how this affects NMDAR-dependent memory 76 
trace formation across central circuits. In the latter context, developing an optical 77 
sensor for the other endogenous NMDAR co-agonist, D-serine, should be high on 78 
the priority list, to help understand how the two co-agonists interact in providing an 79 
'optimal' availability of NMDARs in the brain.  80 
 81 
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FIGURE LEGEND 105 
 106 
Figure 1. An optical sensor to monitor glycine levels in the brain.  107 
a, Amino acid glycine (centre, shape rendering by www.3dchem.com) serves as a 108 
neurotransmitter ligand to the glycine receptor operating a chloride channel (left), 109 
and as a co-agonist for the NMDA receptor operating a Na+/Ca2+ channel (right): the 110 
latter is activated by the main neurotransmitter glutamate upon removal of the 111 
magnesium block.     112 
b, The bacterial protein Atu2422 (from Agrobacterium tumefaciens) binds glycine 113 
(Gly), L-serine (ser), and GABA (i). Aiming at the binding specificity for glycine, the 114 
protein is first mutated at Phe77Ala/Ala100Tyr to prevent GABA binding (ii). Second, 115 
it is mutated at Phe77Ala/Leu202 to suppress L-serine binding, which however 116 
exposes a binding site for glutamate (Glu, iii). To block the latter, Ala100Tyr mutation 117 
is restored to generate the molecule (AYW) providing glycine binding specificity (iv).   118 
c, The FRET sensor is designed by cloning the AYW molecule between the 119 
established FRET pair Venus-ECFP. FRET interaction provides relatively strong 120 
Venus emission in the absence of glycine binding (left) while weakening upon 121 
glycine binding (hence conformational change in AYW), which thus reduces the 122 
Venus/ECFP emission ratio (right).  123 
d, Diagram depicting a dendritic fragment (shaft and spine), presynaptic bouton 124 
(axon), and the surrounding astroglial fragments. Extracellular GlyFS FRET readout 125 
in acute hippocampal slices reveals higher extracellular concentrations of glycine 126 
near dendritic shafts compared to spines (left). Afferent stimulation increases 127 
extracellular glycine concentration (right), which might affect the relative roles of the 128 
two endogenous NMDAR co-agonists, glycine and D-serine.    129 
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